Todd Minga

647 total citations
9 papers, 33 citations indexed

About

Todd Minga is a scholar working on Hematology, Nephrology and Genetics. According to data from OpenAlex, Todd Minga has authored 9 papers receiving a total of 33 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 3 papers in Nephrology and 2 papers in Genetics. Recurrent topics in Todd Minga's work include Erythropoietin and Anemia Treatment (7 papers), Dialysis and Renal Disease Management (3 papers) and Hemoglobinopathies and Related Disorders (2 papers). Todd Minga is often cited by papers focused on Erythropoietin and Anemia Treatment (7 papers), Dialysis and Renal Disease Management (3 papers) and Hemoglobinopathies and Related Disorders (2 papers). Todd Minga collaborates with scholars based in Germany, United States and Canada. Todd Minga's co-authors include Wolfgang C. Winkelmayer, Kai‐Uwe Eckardt, Glenn M. Chertow, Patrick S. Parfrey, Wei Luo, Steven K. Burke, Prabir Roy‐Chaudhury, Youssef M.K. Farag, Susan Arnold and Peter A. McCullough and has published in prestigious journals such as Journal of the American Society of Nephrology, Clinical Pharmacology & Therapeutics and Nephrology Dialysis Transplantation.

In The Last Decade

Todd Minga

7 papers receiving 33 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Todd Minga Germany	3	24	13	10	10	5	9	33
Sarah Vidito United States	4	8 0.3×		3 0.3×	6 0.6×	6 1.2×	4	20
Hiraku Ogata Japan	3	6 0.3×	17 1.3×		1 0.1×	13 2.6×	9	34
I. Serriello Italy	3	5 0.2×	17 1.3×			3 0.6×	5	20
Reyes Sancho-Tello Spain	2	11 0.5×		4 0.4×		12 2.4×	2	20
Ljupco Veskovski Sweden	2	17 0.7×			5 0.5×	15 3.0×	4	21
Sölvi Rögnvaldsson Iceland	3	19 0.8×			3 0.3×	13 2.6×	4	31
Robert Janicek United States	2	11 0.5×			2 0.2×	5 1.0×	3	16
Jayant Kumar United States	2	7 0.3×	5 0.4×			11 2.2×	3	17
Shifa Narula India	6	2 0.1×	12 0.9×		6 0.6×	16 3.2×	6	66
Emeline Boët France	3	9 0.4×		1 0.1×	9 0.9×	11 2.2×	3	22

Countries citing papers authored by Todd Minga

Since Specialization

Citations

This map shows the geographic impact of Todd Minga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Minga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Minga more than expected).

Fields of papers citing papers by Todd Minga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd Minga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Minga. The network helps show where Todd Minga may publish in the future.

Co-authorship network of co-authors of Todd Minga

This figure shows the co-authorship network connecting the top 25 collaborators of Todd Minga. A scholar is included among the top collaborators of Todd Minga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd Minga. Todd Minga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Winkelmayer, Wolfgang C., Steven K. Burke, Glenn M. Chertow, et al.. (2025). Vascular Access Thrombosis Events in Patients With Dialysis-Dependent CKD Treated With Vadadustat or Darbepoetin Alfa: The INNO2VATE Trial Program. Kidney Medicine. 7(5). 100997–100997. 2 indexed citations

Chertow, Glenn M., Kai‐Uwe Eckardt, Mark J. Sarnak, et al.. (2025). Safety and Efficacy of Vadadustat for the Treatment of CKD-Related Anemia within and outside the United States. Journal of the American Society of Nephrology. 36(10). 1984–1997.

Ullman, Julie C., Ryan A. Dick, Todd Minga, et al.. (2024). First‐in‐Human Evaluation of Safety, Pharmacokinetics and Muscle Glycogen Lowering of a Novel Glycogen Synthase 1 Inhibitor for the Treatment of Pompe Disease. Clinical Pharmacology & Therapeutics. 116(6). 1580–1592. 1 indexed citations

Chertow, Glenn M., Alan G. Jardine, Steven K. Burke, et al.. (2024). #2063 Safety and efficacy of vadadustat vs darbepoetin alfa in patients on maintenance dialysis by prespecified subgroups of baseline ESA dose. Nephrology Dialysis Transplantation. 39(Supplement_1). 1 indexed citations

Chertow, Glenn M., Steven K. Burke, Kai‐Uwe Eckardt, et al.. (2024). Long-Term Safety of Vadadustat for Treatment of Anemia-Related CKD in Phase 3 Trials. Journal of the American Society of Nephrology. 35(10S). 1 indexed citations

Winkelmayer, Wolfgang C., Susan Arnold, Steven K. Burke, et al.. (2023). Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non–Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Naïve Patients. Kidney Medicine. 5(7). 100666–100666. 8 indexed citations

Parfrey, Patrick S., Steven K. Burke, Glenn M. Chertow, et al.. (2023). Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non–Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Treated Patients. Kidney Medicine. 5(7). 100667–100667. 6 indexed citations

Winkelmayer, Wolfgang C., Susan Arnold, Steven K. Burke, et al.. (2022). MO536: Cardiovascular Events in Patients With Anemia Associated With Non–Dialysis-Dependent Chronic Kidney Disease: Regional Analysis of Patients not Previously Treated With Erythropoiesis-Stimulating Agents in The PRO2TECT Trial. Nephrology Dialysis Transplantation. 37(Supplement_3).

Koury, Mark J., Rajiv Agarwal, Glenn M. Chertow, et al.. (2022). Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease. American Journal of Hematology. 97(9). 1178–1188. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact